Possible modulation by endothelin-1, nitric oxide, prostaglandin I2 and thromboxane A2 of vasoconstriction induced by an α-agonist in mesenteric arterial bed from diabetic rats

Diabetologia

Volumn 41, Issue 12, 1998, Pages 1410-1418

  Makino, A ^a   Kamata, K ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

1 Agonist; Diabetic rat; Endothelium derived contracting factor; Mesenteric arterial bed

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIN 1; INDOMETACIN; METHOXAMINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NITRIC OXIDE; PROSTACYCLIN; STREPTOZOCIN; THROMBOXANE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; DOSE RESPONSE; ENZYME INHIBITION; HYPOTHESIS; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EPOPROSTENOL; INDOMETHACIN; MALE; MESENTERIC ARTERIES; METHOXAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; THROMBOXANE A2; VASOCONSTRICTION;

EID: 0031742598     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051086     Document Type: Article

References (42)

1. Poston L, Taylor PD (1995) Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 88: 245-255
2. Kamata K, Miyata N, Abiru T, Kasuya Y (1992) Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci 50: 1379-1387
3. Tomlinson KC, Gardinner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103-150
4. Ozturk Y, Aydin S, Altan VM, Yildizoglu-Ari N, Ozecelikay AT (1994) Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 45: 69-112
5. Abebe W, MacLeod KM (1990) Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol 101: 465-471
6. White RE, Carrier GO (1988) Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol 255:H1036-H1042
7. Dresner LS, Wang SP, West MW, Ponomarenko IN, Mueller CM, Wait RB (1997) Nitric oxide inhibition simulates the enhancement of α1 agonist-induced vasoconstriction in diabetes. J Surg Res 70: 119-123
8. Taylor PD, Oon BB, Thomas CR, Poston L (1994) Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenalin-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 111: 35-41
9. White RE, Carrier GO (1990) Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J Pharmacol Exp Ther 253: 1057-1062
10. Hendriks MGC, Kam KL, Fiji AJ, Pfaffendorf M, Vav-Zwieten PA (1993) The effects of hypertension and diabetes mellitus on the vascular reactivity of resistance arteries. Blood Press 2: 69-76
11. Longhurst PA, Head RJ (1985) Responses of the isolated perfused mesenteric vasculature from diabetic rats: The significance of appropriate control tissues. J Pharmacol Exp Ther 235: 45-49
12. Yanagisawa M, Kurihara H, Kimura S et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 322: 411-415
13. Furchgott RF (1983) Role of the endothelium in responses of vascular smooth muscle. Circ Res 53: 557-573
14. Furchgott RF, Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018
15. Vanhoutte PM (1989) Endolhelium and control of vascular function: State of the art lecture. Hypertension 13: 658-667
16. Gryglewski RJ, Botting RM, Vane JR (1988) Mediators produced by the endothelial cells. Hypertension 12: 530-548
17. Kamata K, Hayashi T, Umeda F (1997) Persistence of cyclopiazonic acid-induced endothelium-dependent vasodilatation in spontaneously hypertensive and streptozotocin-induced diabetic rats. Jpn J Pharmacol 73: 247-250
18. Nichols AJ, Wilson AC, Hilley CR (1985) Effects of sympathectomy with 6-hydroxydopamine on cardiac output and its distribution in the rat. Eur J Pharmacol 109: 263-268
19. Dubowski KM (1962) An O-toluidine method for body-fluid glucose determination. Clin Chem 8: 215-235
20. Kamata K, Umeda F, Kasuya Y (1996) Possible existence of novel endothelium-derived relaxing factor in the endothelium of rat mesenteric arterial bed. J Cardiovasc Pharmacol 27: 601-606
21. Kamata K, Makino A (1997) A comparative study on the rat aorta and mesenteric arterial bed of the possible role of nitric oxide in the desensitization of the vasoconstrictor response to an α1-adrenoceptor agonist. Br J Pharmacol 120: 1221-1228
22. Abiru T, Watanabe Y, Kamata K, Kasuya Y (1993) Simultaneous measurement of vasodilation and changes in cyclic nucleotides in perfused mesenteric arterial bed of rat. Eur J Pharmacol 242: 15-22
23. Feletou M, Moreau N, Duhault J (1994) Vascular responsiveness in young, diabetic, and aging hyperinsulinemic rats. Life Sci 54: 1801-1813
24. Murray P, Pitt B, Webb RC (1994) Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 37: 664-670
25. Hendriks MGC, Kam KL, Pijl AJ, Pfaffendorf M, Vav-Zwieten PA (1993) The effects of hypertension and diabetes mellitus on the vascular reactivity of resistance arteries. Blood Press 2: 69-76
26. Heygate KM, Davies J, Holmes M, James RFL, Thurston H (1996) The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat. Br J Pharmacol 119: 459-504
27. Kamata K, Satoh T, Tanaka H. Shigenobu K (1997) Changes in electrophysiological and mechanical responses of the rat papillary muscle to α- and β-agonist in streptozotocin-induced diabetes. Can J Physiol Pharmacol 75: 781-788
28. A receptor. Life Sci 50: 247-255
29. Ishikawa K, Ihara M, Noguchi K et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonists. BO-788. Proc Natl Acad Sci USA 91: 4892-4896
30. Ogletree M, Harris DN, Greenberg R, Haslanger MF, Nakane M (1985) Pharmacological actions of SQ 29548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 234: 435-441
31. Fujii K, Soma M, Huang Y-S, Manku MS, Horrobin DF (1986) Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: The effects of glucose and insulin. Prostaglandins Leukotrienes Med 24: 151-161
32. Koltai MZ, Hadhazy P, Posa I et al. (1997) Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res 34:157-163
33. Corbett JA, Kwon G, Marino MH et al. (1996) Tyrosine kinase inhibitors prevent cyctokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol 270: C1581-C1587
34. McDaniel ML, Kwon CJ, Hill JR, Marshall CA, Corbert JA (1966) Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 211: 24-32
35. Goto K, Hama H, Kasuya Y (1996) Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 72: 261-290
36. D'orleans-juste P, Claing A, Warner TD, Yano M, Telemaque S (1993) Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol 110: 687-692
37. Warner TD (1990) Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. Br J Pharmacol 99: 427-433
38. Simonson MS, Dunn MJ (1992) The molecular mechanisms of cardiovascular and renal regulation of endothelin peptides. J Lab Clin Med 119: 622-639
39. Sokolovsky M (1992) Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol Ther 54: 129-149
40. Yamamoto T, Hosoki K, Karasawa T (1993) Possible involvement of endothelin in thromboxane A2 receptor agonist (U-46619)-induced angina in the rat. Eur J Pharmacol 250: 189-191
41. Taddei S, Vanhoutte PM (1993) Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. J Cardiovasc Pharmacol 22:S328-S331
42. Makino A, Kamata K (1998) Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123: 1065-1072